Epigral Targets Rs. 50 bn Revenue by FY31 Through Capacity Expansion
ECONOMY & POLICY

Epigral Targets Rs. 50 bn Revenue by FY31 Through Capacity Expansion

Specialty chemicals manufacturer Epigral is targeting revenue of Rs. 50 bn by FY31, supported by production capacity expansions in chlorinated polyvinyl chloride (CPVC) resin and epichlorohydrin (ECH), Chairman and Managing Director Maulik Patel said. The company expects revenue to reach Rs. 29 bn in the current financial year, compared with Rs. 25-25.3 bn reported for FY26.

Epigral is doubling its CPVC resin capacity from 75,000 t to 150,000 t annually and its ECH capacity from 50,000 t to 100,000 t. Both projects are located at the company’s existing units in Dahej, Gujarat, and are expected to be commissioned within the next few months.

The expansion phase involves capital expenditure of Rs. 6.5 bn, which has been funded entirely through internal accruals. The projects are expected to make a partial contribution to revenue during the current financial year and a more meaningful contribution from the next financial year as the additional capacity is utilised.

Epigral entered the ECH and CPVC resin businesses in 2022 after deciding to focus on import-substitution products. The company produces ECH using a renewable glycerine-based process rather than the crude-oil-based propylene route commonly used in Western markets. It has also established itself as India’s largest CPVC resin producer and aims to become the world’s largest manufacturer in the category after the capacity expansion.

The company has acquired additional land near its Dahej facility for a new chemistry line and is finalising a technology partner. The project is expected to be placed before the board in another quarter and will target a product for which about 90 per cent of Indian demand is currently met through imports. Patel did not disclose the planned capital expenditure but said it would exceed Rs. 10 bn.

Specialty chemicals manufacturer Epigral is targeting revenue of Rs. 50 bn by FY31, supported by production capacity expansions in chlorinated polyvinyl chloride (CPVC) resin and epichlorohydrin (ECH), Chairman and Managing Director Maulik Patel said. The company expects revenue to reach Rs. 29 bn in the current financial year, compared with Rs. 25-25.3 bn reported for FY26. Epigral is doubling its CPVC resin capacity from 75,000 t to 150,000 t annually and its ECH capacity from 50,000 t to 100,000 t. Both projects are located at the company’s existing units in Dahej, Gujarat, and are expected to be commissioned within the next few months. The expansion phase involves capital expenditure of Rs. 6.5 bn, which has been funded entirely through internal accruals. The projects are expected to make a partial contribution to revenue during the current financial year and a more meaningful contribution from the next financial year as the additional capacity is utilised. Epigral entered the ECH and CPVC resin businesses in 2022 after deciding to focus on import-substitution products. The company produces ECH using a renewable glycerine-based process rather than the crude-oil-based propylene route commonly used in Western markets. It has also established itself as India’s largest CPVC resin producer and aims to become the world’s largest manufacturer in the category after the capacity expansion. The company has acquired additional land near its Dahej facility for a new chemistry line and is finalising a technology partner. The project is expected to be placed before the board in another quarter and will target a product for which about 90 per cent of Indian demand is currently met through imports. Patel did not disclose the planned capital expenditure but said it would exceed Rs. 10 bn.

Related Stories

Gold Stories

Next Story
Resources

Schindler named among Forbes’ World’s Best Employers 2026

Schindler has been named among Forbes’ World’s Best Employers 2026, a global ranking recognising companies for their workplace environments.Compiled by Forbes in partnership with Statista, the ranking is based on independent employee feedback, including whether employees would recommend their organisation to friends and family.The company said the recognition reflected its focus on creating a workplace where employees can develop their expertise and build careers. ..

Next Story
Infrastructure Urban

India needs an export-execution mindset: Vishesh Jain

Interview with Vishesh Jain, Founder & CEO, EximpleWhat gaps in India’s global trade ecosystem led you to build Eximple, and what problem did you see businesses struggling with most?Eximple came out of a problem that all three founders had seen from different choke points in the trade ecosystem. India has millions of MSMEs and manufacturers, and many of them can make products that are genuinely competitive on quality. Yet only a small fraction is able to build meaningful international businesses. In our experience, the gap is usually not manufacturing capability; it is the ability to exe..

Next Story
Building Material

Nuvoco reports 13.5% revenue growth in Q2 FY27

Nuvoco Vistas Corp. Ltd. reported consolidated revenue of Rs 27.9 billion for Q2 FY27, up 13.5% year on year. Cement sales volume rose 9% to 4.7 million tonnes (MMT), while EBITDA increased 11% to Rs 4.11 billion.The company said it began its cement operations in 2014 with a 2.3 MMT per annum (MMTPA) operation at Nimbol. It now aims to reach 35 MMTPA of cement capacity by FY28, nearly 15 times its initial capacity. Its portfolio spans cement, ready-mix concrete and modern building materials.On sustainability and cost efficiency, Nuvoco partnered with CleanMax for a 46.4 MW wind-solar hybrid re..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

SPECIAL OFFER
QR Code